hugh news in itself right here "Expected timi
Post# of 148175
"Expected timing of the Company’s filing for a new request for Breakthrough Therapy Designation for the treatment of 22 different solid tumor cancers
Anticipated timing of potential approval by TFDA (Taiwanese FDA) of leronlimab for the treatment of cancer, HIV and coronavirus
Anticipated timing of potential approval by CFDA (Chinese FDA) of leronlimab for the treatment of cancer and coronavirus
Testimony from cancer patients regarding their experiences with leronlimab for cancer treatment
Overview of ongoing licensing opportunities with several countries for the use of leronlimab for the treatment of HIV, cancer and coronavirus
Management will dedicate approximately 45 minutes to address questions from analysts and investors."